These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28444182)

  • 21. Recent developments in the subcutaneous ICD.
    Willcox ME; Prutkin JM; Bardy GH
    Trends Cardiovasc Med; 2016 Aug; 26(6):526-35. PubMed ID: 27079889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
    Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The implantable cardiac defibrillator.
    Kamalvand K; Gill JS
    Br J Hosp Med; 1996 Jan 17-Feb 6; 55(1-2):37-41. PubMed ID: 8646390
    [No Abstract]   [Full Text] [Related]  

  • 24. Spontaneous onset of ventricular fibrillation during atrioventricular nodal reentrant tachycardia.
    von Bary C; Deisenhofer I; Zrenner B; Hessling G
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):449-50. PubMed ID: 19017350
    [No Abstract]   [Full Text] [Related]  

  • 25. Transvenous ICD lead malposition in the left ventricle: long-term follow-up.
    Franck H; Wollschläger H
    Clin Res Cardiol; 2013 Feb; 102(2):159-61. PubMed ID: 22868694
    [No Abstract]   [Full Text] [Related]  

  • 26. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 27. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death].
    Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE
    Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular implantable electronic devices in athletes.
    Do R; Patton KK
    Cardiovasc Ther; 2010 Oct; 28(5):327-36. PubMed ID: 20553287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Underdetection of Ventricular Fibrillation by Wearable Cardioverter-Defibrillator Leading to Sudden Death.
    Kokubun H; Miyauchi Y; Inada S; Shimizu W
    Circ J; 2020 Dec; 85(1):79. PubMed ID: 33208580
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two hearts synchronized each other with a DDD pacemaker.
    Brunacci M; Valbusa A; Brunelli C; Bertero G
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e239-e240. PubMed ID: 28481822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inappropriate shock despite successful termination of supraventricular tachycardia by antitachycardia pacing during charging.
    Bernier M; Essebag V
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):e81-3. PubMed ID: 20230474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic malignant premature ventricular contractions.
    Ip JE; Lerman BB
    Trends Cardiovasc Med; 2018 May; 28(4):295-302. PubMed ID: 29254831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catastrophic failure of Durata ICD lead due to high-voltage short during shock delivery.
    Schloss EJ; Krebs ME; Gupta M
    Heart Rhythm; 2014 Oct; 11(10):1733-4. PubMed ID: 24931635
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D; Ringquist S; Nickenig G; Andrié R
    PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Present guidelines for device implantation: clinical considerations and clinical challenges from pacing, implantable cardiac defibrillator, and cardiac resynchronization therapy.
    Poole JE
    Circulation; 2014 Jan; 129(3):383-94. PubMed ID: 24446408
    [No Abstract]   [Full Text] [Related]  

  • 37. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
    Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
    [No Abstract]   [Full Text] [Related]  

  • 38. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 39. Differentiation of ventricular tachycardia from ventricular fibrillation using intraventricular electrogram morphology.
    DiCarlo LA; Jenkins JM; Winston SA; Kriegler C
    Am J Cardiol; 1992 Sep; 70(7):820-2. PubMed ID: 1519540
    [No Abstract]   [Full Text] [Related]  

  • 40. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
    Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.